HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $12,000 | 0.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $12,000 | +33.3% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $9,000 | -25.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $12,000 | +50.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $8,000 | -11.1% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $9,000 | -47.1% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $17,000 | +30.8% | 1,000 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $13,000 | -43.5% | 1,000 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $23,000 | +187.5% | 1,000 | 0.0% | 0.01% | +150.0% |
| Q3 2014 | $8,000 | -20.0% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $10,000 | -23.1% | 1,000 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $13,000 | -7.1% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q4 2013 | $14,000 | +27.3% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $11,000 | +57.1% | 1,000 | 0.0% | 0.00% | +33.3% |
| Q2 2013 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |